Michael Bison

Michael Bison is a senior partner in Goodwin’s nationally and internationally recognized Life Sciences practice group. He represents privately held and publicly traded companies across the spectrum of the life sciences industry, including biotechnology, medical devices, diagnostics and healthcare information technology.

Michael typically serves as the primary outside general counsel to his clients, closely advising management teams and boards of directors on a wide variety of matters throughout the company’s life cycle, including company formation and founder issues, venture capital and growth equity financings, public offerings, M&A, strategic collaborations, commercial transactions, corporate governance and general corporate matters. He is regularly recognized by his clients for his extensive industry knowledge and for providing practical, result-oriented legal advice.

Michael has advised numerous international companies with respect to their U.S. listings, capital markets transactions, strategic collaborations and M&A transactions, as well as with respect to the establishment of U.S. subsidiaries and various operational matters with respect to these subsidiaries.

Michael also regularly represents leading venture capital firms focused on the life sciences industry in connection with their portfolio company investments, exits and secondary stock sale transactions, as well as underwriters focused on the life sciences industry in connection with capital market and M&A transactions.